Cargando…

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2

The outbreak of COVID-19 has severely impacted global health and the economy. Cost-effective, highly efficacious therapeutics are urgently needed. Here, we used camelid immunization and proteomics to identify a large repertoire of highly potent neutralizing nanobodies (Nbs) to the SARS-CoV-2 spike (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Yufei, Nambulli, Sham, Xiao, Zhengyun, Liu, Heng, Sang, Zhe, Duprex, W. Paul, Schneidman-Duhovny, Dina, Zhang, Cheng, Shi, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457627/ https://www.ncbi.nlm.nih.gov/pubmed/32869034 http://dx.doi.org/10.1101/2020.08.24.264333

Ejemplares similares

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Superimmunity by pan-sarbecovirus nanobodies
por: Xiang, Yufei, et al.
Publicado: (2022)

A resource of high-quality and versatile nanobodies for drug delivery
por: Shen, Zhuolun, et al.
Publicado: (2021)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning
por: Cohen, Tomer, et al.
Publicado: (2022)

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
por: Nambulli, Sham, et al.
Publicado: (2021)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
por: Lu, Yuying, et al.
Publicado: (2023)

Predicting structures of large protein assemblies using combinatorial assembly algorithm and AlphaFold2
por: Shor, Ben, et al.
Publicado: (2023)

Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes
por: Wade, Jack, et al.
Publicado: (2022)

The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor
por: Brielle, Esther S., et al.
Publicado: (2020)

Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
por: Sadeghnezhad, Golnaz, et al.
Publicado: (2019)

Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
por: Sánchez-García, Laura, et al.
Publicado: (2021)

Reduced antigenicity of Omicron lowers host serologic response
por: Tubiana, Jérôme, et al.
Publicado: (2022)

Reduced B cell antigenicity of Omicron lowers host serologic response
por: Tubiana, Jérôme, et al.
Publicado: (2022)

FoXS: a web server for rapid computation and fitting of SAXS profiles
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2010)

Integrative structural modeling with small angle X-ray scattering profiles
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2012)

Llamanade: an open-source computational pipeline for robust nanobody humanization
por: Sang, Zhe, et al.
Publicado: (2021)

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
por: Wang, Jiewen, et al.
Publicado: (2022)

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
por: Pymm, Phillip, et al.
Publicado: (2021)

Developing lectins as inhibitors of SARS-CoV2
por: Guseman, Alex J., et al.
Publicado: (2022)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Nanobodies as Versatile Tool for Multiscale Imaging Modalities
por: Erreni, Marco, et al.
Publicado: (2020)

PatchDock and SymmDock: servers for rigid and symmetric docking
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2005)

FoXS, FoXSDock and MultiFoXS: Single-state and multi-state structural modeling of proteins and their complexes based on SAXS profiles
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2016)

Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications
por: Vorobyeva, Mariya, et al.
Publicado: (2016)

Mapping the evolutionary trajectories of morbilliviruses: what, where and whither
por: Nambulli, Sham, et al.
Publicado: (2016)

Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
por: Guseman, Alex, et al.
Publicado: (2023)

Sortase A transpeptidation produces seamless, unbranched biotinylated nanobodies for multivalent and multifunctional applications
por: Obeng, Eugene M., et al.
Publicado: (2023)

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
por: Koenig, Paul-Albert, et al.
Publicado: (2021)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

FireDock: a web server for fast interaction refinement in molecular docking(†)
por: Mashiach, Efrat, et al.
Publicado: (2008)

PharmaGist: a webserver for ligand-based pharmacophore detection
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2008)

Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels
por: Scherger, Maximilian, et al.
Publicado: (2020)

CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)

Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
por: Liu, Honghui, et al.
Publicado: (2023)

Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
por: Pymm, Phillip, et al.
Publicado: (2022)

A robust pipeline for rapid production of versatile nanobody repertoires
por: Fridy, Peter C., et al.
Publicado: (2014)

Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer
por: Van Audenhove, Isabel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_677b0i89rofrfa4dpc5f32m5e5